Related references
Note: Only part of the references are listed.Mechanisms of apoptosis resistance and treatment strategies to overcome them in hormone-refractory prostate cancer
Robert G. Uzzo et al.
CANCER (2008)
Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1
Eiji Furuta et al.
CANCER RESEARCH (2008)
Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells
A. Vazquez-Martin et al.
CELL PROLIFERATION (2008)
Discovery of GSK837149A, an inhibitor of human fatty acid synthase targeting the β-ketoacyl reductase reaction
Maria Jesus Vazquez et al.
FEBS JOURNAL (2008)
Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model
Marco A. Carvalho et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Vitamins E and C in the Prevention of Cardiovascular Disease in Men The Physicians' Health Study II Randomized Controlled Trial
Howard D. Sesso et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Synthesis of novel β-lactone inhibitors of fatty acid synthase
Robyn D. Richardson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer
Amy L. Vavere et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction
Hailan Liu et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis
Jing Ma et al.
LANCET ONCOLOGY (2008)
Multiple newly identified loci associated with prostate cancer susceptibility
Rosalind A. Eeles et al.
NATURE GENETICS (2008)
The crystal structure of a mammalian fatty acid synthase
Timm Maier et al.
SCIENCE (2008)
Novel targeted pro-apoptotic agents for the treatment of prostate cancer
Xu Huang et al.
JOURNAL OF UROLOGY (2007)
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Javier A. Menendez et al.
NATURE REVIEWS CANCER (2007)
Chemical inhibition of Acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells
Annelies Beckers et al.
CANCER RESEARCH (2007)
Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride
Lucy J. Schmidt et al.
PROSTATE (2007)
The apoptosome: signalling platform of cell death
Stefan J. Riedl et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality
Margaret E. Wright et al.
CANCER (2007)
Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort
Carmen Rodriguez et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Obesity, diabetes, and risk of prostate cancer: Results from the prostate cancer prevention trial
Zhihong Gong et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
The isopeptidase USP2a protects human prostate cancer from apoptosis
Carmen Priolo et al.
CANCER RESEARCH (2006)
Gastrointestinal stromal turnours overexpress fatty acid synthase
S. Rossi et al.
JOURNAL OF PATHOLOGY (2006)
Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma
US Shah et al.
HUMAN PATHOLOGY (2006)
Role of diet in prostate cancer development and progression
JM Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
ATP citrate lyase inhibition can suppress tumor cell growth
G Hatzivassiliou et al.
CANCER CELL (2005)
RNA interference-mediated silencing of the Acetyl-CoA-Carboxylase-α gene induces growth inhibition and apoptosis of prostate cancer cells
K Brusselmans et al.
CANCER RESEARCH (2005)
High-level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB
T Van de Sande et al.
JOURNAL OF PATHOLOGY (2005)
20-year outcomes following conservative management of clinically localized prostate cancer
PC Albertsen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity
SJ Kridel et al.
CANCER RESEARCH (2004)
Molecular genetics of human prostate cancer
MA Rubin et al.
MODERN PATHOLOGY (2004)
The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer
E Graner et al.
CANCER CELL (2004)
Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells
R Berger et al.
CANCER RESEARCH (2004)
Fatty acid synthase: A metabolic oncogene in prostate cancer?
A Baron et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Height, body mass index, and prostate cancer: a follow-up of 950 000 Norwegian men
A Engeland et al.
BRITISH JOURNAL OF CANCER (2003)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains
JV Swinnen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Mitochondrial control of cell death
G Kroemer et al.
NATURE MEDICINE (2000)
Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells
T Kusakabe et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2000)
Share Paper
